Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Potassium channels--multiplicity and challenges.

Donald H Jenkinson1

  • 1Department of Pharmacology, University College London, Gower St., London WC1E 6BT. d.jenkinson@ucl.ac.uk

British Journal of Pharmacology
|January 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Further studies on bis-charged tetraazacyclophanes as potent inhibitors of small conductance Ca(2+)-activated K+ channels.

European journal of medicinal chemistry·2013
Same author

Synthesis and pharmacological testing of polyaminoquinolines as blockers of the apamin-sensitive Ca2+-activated K+ channel (SK(Ca)).

Bioorganic & medicinal chemistry·2007
Same journal

Tangeretin ameliorates sepsis-induced neurocognitive impairment in adult male mice by suppressing Akt-driven glycolytic reprogramming and neuroinflammation.

British journal of pharmacology·2026
Same journal

The discovery and development of ensifentrine: A novel inhaled dual PDE3/4 inhibitor having 'bifunctional' bronchodilator and anti-inflammatory activity.

British journal of pharmacology·2026
Same journal

Glucagon-like peptide-1 improves vascular endothelial dysfunction in hypertensive mice via CREB-driven transcriptional regulation of long non-coding RNA 155383.

British journal of pharmacology·2026
Same journal

The chemokine receptor-like fourth extracellular loop of the apelin receptor differentially regulates apelin and elabela binding and signalling.

British journal of pharmacology·2026
Same journal

Peripheral targets for neuropathic pain.

British journal of pharmacology·2026
Same journal

Therapeutic potential of liver X receptor agonist GW3965 in preserving myelin integrity following traumatic brain injury.

British journal of pharmacology·2026
See all related articles

Potassium (K+) channels are highly diverse, offering potential for new drugs targeting various diseases. However, their widespread presence demands highly selective drug development, posing a significant challenge.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Neuroscience

Background:

  • Potassium (K+) channels represent the most diverse ion channel family, with at least 75 coding genes in mammals.
  • Functional K+ channels arise from complex assemblies of various subunits and accessory proteins, further increased by alternative splicing.

Observation:

  • The extensive diversity of K+ channels suggests potential for novel therapeutic agents.
  • Animal toxins offer valuable starting points for drug discovery, though developing non-peptidic analogues with high potency is difficult.

Findings:

  • Developing selective K+ channel modulators is challenging due to the ubiquitous nature of these channels throughout the body.
  • Identifying and fully characterizing specific K+ channel targets requires substantial resources.

Related Experiment Videos

Implications:

  • Targeting K+ channels could lead to new treatments for immunomodulation and central nervous system disorders.
  • Significant academic and applied pharmacological efforts are needed to overcome selectivity challenges in K+ channel drug development.